Globus Medical, Inc. Class A Common Stock (GMED)
R&D Expenses
$36.32M
Quarterly · Period ending: · USD
GMED R&D Expenses
Latest reported$36.32Mperiod ending
Latest reported$36.32Mperiod ending
GMED Quarterly R&D Expenses ($6.04M → $36.32M)
Quarterly R&D Expenses
High-resolution chart · PNG
GMED r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 36,321,000 | |
| 36,510,000 | |
| 73,917,000 | |
| 38,067,000 | |
| 39,954,000 | |
| 33,062,000 | |
| 33,408,000 | |
| 35,380,000 | |
| 37,698,000 | |
| 57,268,000 | |
| 52,252,000 | |
| 29,329,000 | |
| 21,347,000 | |
| 21,082,000 | |
| 19,507,000 | |
| 18,701,000 | |
| 17,395,000 | |
| 17,412,000 | |
| 51,022,000 | |
| 15,853,000 | |
| 15,547,000 | |
| 14,924,000 | |
| 15,241,000 | |
| 14,421,000 | |
| 39,455,000 | |
| 15,402,000 | |
| 15,496,000 | |
| 14,508,000 | |
| 15,746,000 | |
| 14,324,000 | |
| 13,758,000 | |
| 15,527,000 | |
| 13,523,000 | |
| 12,689,000 | |
| 11,413,000 | |
| 10,887,000 | |
| 10,713,000 | |
| 10,666,000 | |
| 13,643,000 | |
| 10,265,000 | |
| 10,594,000 | |
| 10,030,000 | |
| 9,836,000 | |
| 9,250,000 | |
| 9,081,000 | |
| 8,656,000 | |
| 8,404,000 | |
| 8,146,000 | |
| 7,694,000 | |
| 7,443,000 | |
| 6,418,000 | |
| 6,568,000 | |
| 7,037,000 | |
| 6,847,000 | |
| 7,228,000 | |
| 7,022,000 | |
| 6,940,000 | |
| 6,736,000 | |
| 5,773,000 | |
| 5,916,000 | |
| 5,735,000 | |
| 6,040,000 |